CFFP
ADMA icon

Center for Financial Planning’s ADMA Biologics ADMA Stock Holding History

Center for Financial Planning’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Hold
1,500
– – ﹤0.01% 475
2026
Q1 		$13.5K Hold
1,500
– – ﹤0.01% 459
2025
Q4 		$27.4K Hold
1,500
– – ﹤0.01% 375
2025
Q3 		$22K Buy
+1,500
New +$25.7K ﹤0.01% 407
2021
Q3 		– Sell
-380
Closed -$1K – 488
2021
Q2 		$1K Buy
+380
New +$669 ﹤0.01% 471

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Center for Financial Planning's ADMA Position: Q2 2026 in Review

Center for Financial Planning held its ADMA Biologics (ADMA) position steady in Q2 2026 at 1,500 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Center for Financial Planning first reported a position in ADMA in Q2 2021 and has held it in 5 quarters since. The position peaked at $27.4K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Center for Financial Planning held 1,500 shares of ADMA Biologics worth $12.6K as of Q2 2026.
  • Center for Financial Planning left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #475 holding.
  • Center for Financial Planning first reported a position in ADMA Biologics in Q2 2021 and has held it in 5 quarters since.
  • Center for Financial Planning's ADMA Biologics position peaked at $27.4K in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.